EFFICACY OF INCOBOTULINUMTOXINA FOR TREATMENT OF GLABELLAR FROWN LINES IN MALE SUBJECTS: POST HOC ANALYSES FROM RANDOMIZED, DOUBLE-BLIND PIVOTAL STUDIES

被引：0
|
作者：
Jones, Derek H. [1 ]
Kerscher, Martina [2 ]
Geister, Thorin [3 ]
Hast, Michael A. [4 ]
Weissenberger, Petra [3 ]
机构：
[1] Skin & Laser Phys Beverly Hills, Beverly Hills, CA USA
[2] Univ Hamburg, Div Cosmet Sci, Hamburg, Germany
[3] Merz Pharmaceut GmbH, Frankfurt, Germany
[4] Merz North Amer, Raleigh, NC USA
来源：
TOXICON | 2018年 / 156卷
关键词：
Aesthetic use; Efficacy; IncobotulinumtoxinA; Male cohort; Post hoc analysis;
D O I：
10.1016/j.toxicon.2018.11.124
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
114
引用
收藏
页码：S52 / S52
页数：1
相关论文
共 50 条
  • [31] Efficacy and Safety of Botulinum Toxin Type A in the Treatment of Glabellar Lines: A Meta-Analysis of Randomized, Placebo-Controlled, Double-Blind Trials
    Guo, Yu
    Lu, Yongzhou
    Liu, Tianyi
    Zhou, Yiqun
    Yang, Ping
    Zhu, Jingjing
    Chen, Liang
    Yang, Qingjian
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2015, 136 (03) : 310E - 318E
  • [32] A multicenter, randomized, double-blind study to evaluate the efficacy of onabotulinumtoxina (20 units) in the treatment of glabellar lines, when compared to incoboulinumtoxina (30 units)
    Moers-Carpi, Marion
    Fulford-Smith, Antony
    Tan, Kelvin
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 66 (04) : AB20 - AB20
  • [33] A randomized, dose-escalating, double-blind study to evaluate abobotulinumtoxinA for the treatment of moderate-to-severe glabellar lines
    Joseph, John
    Moradi, Amir
    Lorenc, Z. Paul
    Coleman, Kyle
    Ablon, Glynis
    Kaufman-Janette, Joely
    Cox, Sue Ellen
    Campbell, Andrew
    Dayan, Steven
    Munavalli, Girish
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB69 - AB69
  • [34] A Four-Month Randomized, Double-Blind Evaluation of the Efficacy of Botulinum Toxin Type A for the Treatment of Glabellar Lines in Women with Skin Types V and VI
    Grimes, Pearl E.
    Shabazz, Dwana
    DERMATOLOGIC SURGERY, 2009, 35 (03) : 429 - 436
  • [35] A randomized, double-blind, placebo-controlled study of botulinum toxin type a for the treatment of glabellar lines: Determination of optimal dose
    Monheit, Gary
    Carruthers, Alastair
    Brandt, Fredric
    Rand, Rhonda
    DERMATOLOGIC SURGERY, 2007, 33 : S51 - S59
  • [36] Efficacy of Galcanezumab in Adults With Treatment Resistant Migraine and Concomitant Pain Disorders: Post-hoc Subpopulation Analyses From the Randomized, Double-Blind, Placebo-Controlled CONQUER Study
    Argoff, C.
    Dong, Y.
    Li, L. Q.
    Barad, M.
    Wright, P.
    HEADACHE, 2020, 60 : 105 - 106
  • [37] Efficacy of cariprazine in bipolar depression: post hoc band-pass analyses of two randomized, double-blind, placebo-controlled trials
    Yatham, L.
    Vieta, E.
    Durgam, S.
    Earley, W.
    Lu, K.
    Laszlovszky, I.
    Nemeth, G.
    BIPOLAR DISORDERS, 2016, 18 : 182 - 182
  • [38] Efficacy and Safety of a Novel Botulinum Toxin Type A Product for the Treatment of Moderate to Severe Glabellar Lines: A Randomized, Double-Blind, Active-Controlled Multicenter Study
    Won, Chong H.
    Lee, Hyung M.
    Lee, Woo S.
    Kang, Hoon
    Kim, Beom J.
    Kim, Won S.
    Lee, Ju H.
    Lee, Dong H.
    Huh, Chang H.
    DERMATOLOGIC SURGERY, 2013, 39 (01) : 171 - 178
  • [39] SAFETY AND EFFICACY OF INCOBOTULINUMTOXINA FOR THE TREATMENT OF UPPER FACIAL LINES: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY WITH OPEN-LABEL EXTENSION
    Trevidic, Patrick
    Connolly, Simon A.
    Biwer, Bernard
    Weissenberger, Petra
    Kestemont, Philippe
    Noah, Ernst M.
    Sattler, Gerhard
    Kerscher, Martina
    TOXICON, 2018, 156 : S110 - S110
  • [40] Efficacy and safety of incobotulinumtoxinA in post-stroke upper-limb spasticity in Japanese subjects: results from a randomized, double-blind, placebo-controlled study (J-PURE)
    Yoshihisa Masakado
    Masahiro Abo
    Kunitsugu Kondo
    Satoru Saeki
    Eiichi Saitoh
    Andrzej Dekundy
    Angelika Hanschmann
    Ryuji Kaji
    Journal of Neurology, 2020, 267 : 2029 - 2041
12345